IP reconciliation, return, and destruction documentation — Monitoring, Close-Out & the Modern CRC

Free Lesson Preview

This is just the beginning

The full CRC track covers 8 courses from study start-up to close-out — the skills sponsors actually look for.

Already enrolled? Sign in

The arithmetic that must add up to zero

There is a particular kind of anxiety that accompanies the final investigational product reconciliation. It is not the anxiety of complexity -- the math itself is simple enough. You received a certain number of units from the sponsor. You dispensed a certain number to participants. Participants returned a certain number. Some units remain in your pharmacy inventory. Some may have been destroyed under authorization. Add it up, subtract, and the remainder should be zero.

The anxiety comes from knowing what happens when the remainder is not zero. When the numbers do not reconcile -- when even a single tablet, vial, or blister pack cannot be accounted for -- the site has a problem. Not merely a documentation problem, though that is bad enough. A problem that raises questions about participant safety (did someone receive an incorrect dose?), data integrity (are the dispensing records accurate?), and regulatory compliance (can the site demonstrate adequate control of an investigational product?).

I have seen sites where IP reconciliation at close-out was a formality -- ten minutes of arithmetic confirming what everyone already knew. And I have seen sites where it consumed weeks of investigation, generated multiple deviation reports, and delayed the close-out monitoring visit. The difference, almost without exception, was the quality of the site's IP accountability practices during the study itself. Course 5 taught those practices. This lesson assumes them. What we address here is the final act: the definitive reconciliation that closes the books on every unit of investigational product the site ever touched.